Morning Report Newsletter

The Thanksgiving holiday is almost here, and we’ll soon have our fill of turkey, pumpkin pie, and contentious conversations with extended family. When a generous serving of politics and religion heats up the dining room, you can throw another log on the fire with this hot topic: does antihypertensive medication work better when taken in the morning or in the evening?

Read more »

Fall is here! And that means Big Pumpkin will take hold of every consumable product, Bill Belichick will rip into another batch of perfectly good hoodies, and viral respiratory infections will infiltrate half your patient panel. If you had a nickel for every patient who presented with a cold—well, you and the collective medical community would have $5.5 million/year (110 million annual visits). Now, if only you had a nickel for every antibiotic request …

Read more »

The United States Preventive Services Task Force (USPSTF) finalized its statement on the use of statins for primary prevention of cardiovascular disease (CVD) last week, polarizing the medical community like a partisan bill on the Senate floor.

The USPSTF based its recommendation on 23 clinical trials and three observational studies that assessed the head-to-head use of a statin with either placebo or no statin on CVD risk. True to brand, the task force erred on the side of caution and recommended a conservative approach.

Read more »

The World Health Organization’s 2020 recommendations for adult physical activity are clear: engage in ≥150 minutes of moderate-to-vigorous activity or 75 minutes of vigorous activity per week. But does it matter how the minutes are divvied up? According to a new study, nope.

Read more »

Here comes the sun (DO-do-do-do). Fourth of July weekend marks the unofficial start of summer and serves as a reminder to counsel patients on the importance of applying sunscreen. But before you do, the Environmental Working Group (EWG) wants you to check out its 16th Annual Guide to Sunscreens , based on the group’s appraisal of 1,850 products advertising sun protection.

Read more »

Don your bomber jacket and aviator shades for this one. The news out of the AACE’s (American Association of Clinical Endocrinology) annual meeting last month was as welcome and long overdue as the Top Gun sequel. The AACE unveiled the first guidelines for the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) for—wait for it—primary care providers (PCPs) and endocrinologists. Goodness gracious, great balls of fire!

Read more »

Some things we didn’t see coming: the Red Wedding, Tide PODS as a snack, a face slap at the Academy Awards, and certainly not bad press for metformin. This go-to medication has boasted an efficacy and safety profile that are the envy of most drugs, but a new study cautions against its use in would-be fathers.

Read more »

Move over, Peloton—wearable fitness devices stand poised to take over as the fitness trend of 2022. But do these devices really work? Researchers conducted a systematic review and meta-analysis to determine the effectiveness of wearable devices in promoting exercise and weight loss among adults with overweight or obesity.

Read more »

Researchers stoked the fires of a feud older than the Capulets and the Montagues, the Jets and the Sharks, and the Starks and the Lannisters. It’s the clash between cat lovers and dog lovers.

Read more »

We’ve waited 18 years for this. No, we’re not talking about a sequel to Napoleon Dynamite. We’ll still have to wonder if Kip’s cage fighting-career ever takes off. Instead, we’re talking about the update to the Centers for Disease Control and Prevention’s (CDC) 2004 developmental surveillance checklist . . .

Read more »